A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial

You may be eligible if

• Subject must currently be participating in an Astellas sponsored linsitinib trial that has ended with respect to the overall study analysis.
• Subject must not have met criteria for discontinuation or have progressed on the current linsitinib study in which they are participating.
• Subject must be deriving benefit from continued treatment.